hotspot -WSS

hotspot

author：focus 2025-09-30 13:14:08 - browse：4394

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Study: Why relieving medical debt did not improve financial outcomes

WSS

Novo: Oral version of Ozempic leads to 15% weight loss

Report captures long Covid’s disabling effects and policy challenges

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Xenotransplantation trials will require adjusting expectations, experts say

Cigna wins case to block Amy Bricker's move to CVS

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

entertainment

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Wildfire smoke exposes gaps in outdoor worker protections

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

At least 13 dead in Texas as scorching temps continue

Timeline: Key moments in fight for gay rights

Medicare details structure of new drug price negotiation program

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Guidelines to prevent youth baseball injuries need more muscle

Novo: Oral version of Ozempic leads to 15% weight loss

focus

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Millions may soon lose Medicaid when they don't have to

How to fix the rural physician shortage in the U.S.

A public health expert passes on football's full body collisions for youths

Moderna says combo Covid

Xenotransplantation trials will require adjusting expectations, experts say

explore

entertainment

entertainment

hotspot